Search results
Who we are. Researchers of Psychedelics, Leaders of Change. Founded in 1986, MAPS is a 501 (c) (3) nonprofit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana. MAPS previously sponsored the most advanced psychedelic-assisted therapy ...
- Careers
MAPS advances equity and inclusion in the workplace by...
- Our Team
Rick Doblin, Ph.D., is the Founder and President of the...
- MDMA
Studies to determine the effects of MDMA in healthy...
- Our Research
From sacred rituals to counterculture movements,...
- Careers
The Multidisciplinary Association for Psychedelic Studies (MAPS) is an American nonprofit organization working to raise awareness and understanding of psychedelic substances. MAPS was founded in 1986 by Rick Doblin and is now based in San Jose, California.
Sep 14, 2023 · MDMA pills used in a study on the drug’s effectiveness as a treatment for post-traumatic stress disorder in veterans. Multidisciplinary Association for Psychedelic Studies. MDMA-assisted...
Feb 19, 2024 · MAPS Public Benefit Corporation (PBC) has made history by submitting the first New Drug Application (NDA) to the FDA for Psychedelic-Assisted Therapy. The NDA is based on Phase 3 clinical trials using MDMA for post-traumatic stress disorder (PTSD), depression, and anxiety.
MAPS supports the careful uses of psychedelics and marijuana for medical, legal, and cultural purposes. Learn about their research, training, and advocacy projects, events, and updates on LinkedIn.
People also ask
Does NIDA have a monopoly on psychedelic drugs?
What is the Multidisciplinary Association for Psychedelic Studies (MAPS)?
Who are psychedelics researchers?
Are maps therapists pinning down a clinical trial participant for MDMA for PTSD?
